Chief Medical OfficerMen's Health Foundation, Los Angeles, CA, USALos Angeles, California, United States
Disclosure information not submitted.
129 - Pooled safety and tolerability of twice-yearly lenacapavir with teropavimab and zinlirvimab for HIV-1 treatment
Monday, October 20, 202512:30 PM - 12:35 PM US ET